Promising Results From Early Trials of Fentanyl Vaccine

WHO:

NBC News - The drugmaker involved is ARMR Sciences.

WHAT:

NBC News - An experimental vaccine aimed at preventing fentanyl overdoses showed promise in an early-stage clinical trial.

NBC News - The vaccine could potentially be used to help prevent overdoses and treat addiction.

HOW:

NBC News - The vaccine is designed to combat the opioid crisis.

(UPDATED June 18, 2026 06:42 UTC)

An experimental vaccine developed by ARMR Sciences aimed at preventing fentanyl overdoses has shown promise in early-stage clinical trials. This innovative vaccine could potentially help prevent overdoses and treat addiction, addressing the ongoing opioid crisis. Researchers are hopeful that this breakthrough could lead to significant advancements in public health efforts against opioid-related challenges.